Evidence showed KCNJ5-mutant carriers were younger, had higher levels of preoperative aldosterone, more severe hypokalemia, and had a better hypertension prognosis after adrenalectomy than non-mutant carriers [9, 12–14]. This evidence concerns the gene KCNJ5 and Hypertension.